Regulation of potassium channels in coronary arterial smooth muscle by endothelium-derived vasodilators

Hypertension

Volumn 29, Issue 1 II, 1997, Pages 262-267

  Li, Pin Lan ^a   Zou, Ai Ping ^a   Campbell, William B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

coronary artery; endothelium; epoxyeicosatrienoic acids; nitric oxide; potassium channels; prostacyclin

Indexed keywords

ENDOTHELIUM DERIVED RELAXING FACTOR; NITRIC OXIDE; POTASSIUM CHANNEL; PROSTACYCLIN;

ANIMAL CELL; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; BLOOD VESSEL TONE; CONCENTRATION RESPONSE; CORONARY ARTERY; CORONARY BLOOD VESSEL; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0031025760     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.29.1.262     Document Type: Article

References (35)

1. Vane JR, Botting RM. Secretory functions of the vascular endothelium. J Physiol Pharmacol. 1992;43:195-207.
2. Mehta JL, Fla G. Endothelium, coronary vasodilation, and organic nitrates. Am Heart J. 1995;129:382-391.
3. Suzuki H, Chen G, Yamamoto Y. Endothelium-derived hyperpolarizing factor (EDHF). Jpn Circ J. 1992;56:170-174.
4. Vanhoutte PM, Rubanyi GM, Miller VM, Housten DS. Modulation of vascular smooth muscle contraction by the endothelium. Annu Rev Physiol. 1986;48:307-323.
5. Myers PR, Guerra R Jr, Harrison DG. Release of multiple endothelium-derived relaxing factors from porcine coronary arteries. J Cardiovasc Pharmacol. 1992;20:392-400.
6. Rubanyi GM, Vanhoutte PM. Nature of endothelium-derived relaxing factor: are there two relaxing mediators? Circ Res. 1987;61(suppl II):II-61-II-67.
7. Campbell WB, Gebremadhin D, Pratt P, Harder DR. Identification of epoxyeicosatrienoic acid as endothelium-derived hyperpolarizing factors. Circ Res. 1996;78:415-423.
8. Argus JR, Cocks TM. Endothelium-derived relaxing factor. Pharmacol Ther. 1989;41:303-351.
9. Nelson MT, Quayle JM. Physiological role and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995; 268:C799-C822.
10. Siegel G, Emden J, Wenzel K, Mironneau J, Stock G. Potassium channel activation in vascular smooth muscle. In: Frank GB, Bianchi CP, Ter Kevers HEDJ, eds. Excitation-Contraction Coupling in Skeletal, Cardiac, and Smooth Muscle. New York, NY: Plenum Press; in press.
11. Hamill OP, Neher MR, Sakmann B. Improved patch clamp techniques for high-resolution current recording from cell and cell-free membrane patches. Pflugers Arch. 1981;391:85-100.
12. Godt RE. Calcium-activated tension of skinned muscle fibers of the frog. J Gen Physiol. 1974;63:722-739.
13. 2 (prostacyclin) by cultured human and bovine endothelial cells. Proc Natl Acad Sci U S A. 1977;74:3922-3926.
14. Miller OV, Aiken JW, Hemker DP, Shebuski RJ, Gorman RR. Prostacyclin stimulation of dog arterial cyclic AMP levels. Prostaglandins. 1979;18:915-925.
15. + channel in canine renal artery: novel mechanisms for agonist-induced membrane depolarization. Circ Res. 1995;77:121-130.
16. Adeagbo AS, Malik KU. Mechanism of vascular actions of prostacyclin in the rat isolated perfused mesenteric arteries. J Pharmacol Exp Ther. 1989;252:26-34.
17. + channel in coronary artery smooth muscle and its role in vasodilation. FEBS Lett. 1989;255:281-284.
18. + channels and depolarizes smooth muscle cells of porcine coronary artery. Circ Res. 1992;72:612-616.
19. +-channel activities of cultured smooth muscle cells from porcine coronary artery. Am J Physiol. 1992;263:H491-H496.
20. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
21. Brayden JR. Membrane hyperpolarization is a mechanism of endothelium-dependem cerebral vasodilation. Am J Physiol. 1990;259: H668-H673.
22. Komori K, Lorenz RR, Vanhoutte PM. Nitric oxide, Ach, and electrical and mechanical properties of canine arterial smooth muscle. Am J Physiol. 1988;255:H207-H212.
23. Garland CH, McPherson GA. Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery. Br J Pharmacol. 1992;105:429-435.
24. Tare M, Parkington HC, Coleman HA, Neild TO, Dusting GJ. Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. 1990;346:69-71.
25. Parkington HC, Tare M, Tonta MA, Coleman HA. Stretch revealed three components in the hyperpolarization of guinea-pig coronary artery in response to acetylcholine. J Physiol. 1993;465:459-476.
26. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850-853.
27. Chen GY, Yamamoto K, Miwa K, Suzuki H. Hyperpolarization of arterial smooth muscle induced by endothelial humoral substances. Am J Physiol. 1991;260:H1888-H1892.
28. Van de Voorde J, Vanheel B, Leusen I. Endothelium-dependent relaxation and hyperpolarization in aorta from control and renal hypertensive rats. Circ Res. 1992;70:1-8.
29. Falck JR, Schueler VJ, Jacobson HR, Siddhanta AK, Pramanik B, Capdevila J. Arachidonate epoxygenase: identification of epoxyeicosatrienoic acids in rabbit kidney. J Lipid Res. 1987;28:840-846.
30. Rosolowsky M, Campbell WB. Role of PGI2 and EETs in the relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol. 1993;264:H327-H335.
31. Rosolowsky M, Campbell WB. Synthesis of hydroxyeicosatetraenoic (HETE) and epoxyeicosatrienoic acid (EETs) by cultured bovine coronary artery endothelial cells. Biochim Biophys Acta. 1996;1299:267-277.
32. Hecker M, Bara AT, Bauersachs J, Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol. 1994;481:407-414.
33. Gebremedhin D, Ma Y-H, Roman RJ, Van Rollins M, Harder DR. Cellular mechanism of cerebral epoxyeicosatrienoic acid on cerebral arterial smooth muscle. Am J Physiol. 1992;263:H519-H525.
34. + channel activity. Am J Physiol. 1996; 270:F822-F832.
35. + channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid. Eur J Pharmacol. 1993;230:215-221.